Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8years later

Schizophrenia Research

Volumn 161, Issue 2-3, 2015, Pages 407-413

  Ventura, Joseph ^a   Subotnik, Kenneth L ^a   Gitlin, Michael J ^a   Gretchen Doorly, Denise ^a   Ered, Arielle ^a   Villa, Kathleen F ^c   Hellemann, Gerhard S ^a   Nuechterlein, Keith H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GENENTECH INC   (United States)

Author keywords

BPRS; Functional outcome; Intraclass correlation coefficient; Long term follow up; Negative symptoms; SANS; Schizophrenia; Symptom exacerbation

Indexed keywords

ADULT; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; EDUCATIONAL STATUS; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; POSITIVE SYNDROME; SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOMS; SCHIZOPHRENIA; SCHIZOPHRENIA ASSESSMENT; SCHOOL FUNCTIONING; SOCIAL INTERACTION; WORK FUNCTIONING; CROSS-SECTIONAL STUDY; EMPLOYMENT; FOLLOW UP; LONGITUDINAL STUDY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SCHOOL; SOCIAL BEHAVIOR; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

NEUROLEPTIC AGENT;

ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; EMPLOYMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHOOLS; SOCIAL BEHAVIOR; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84921488563     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.10.043     Document Type: Article

References (41)

1. Albert N., Bertelsen M., Thorup A., Petersen L., Jeppesen P., Le Quack P., Krarup G., Jørgensen P., Nordentoft M. Predictors of recovery from psychosis: analyses of clinical and social factors associated with recovery among patients with first-episode psychosis after 5years. Schizophr. Res. 2011, 125(2-3):257-266.
2. Andreasen N.C. The Scale for the Assessment of Negative Symptoms (SANS) 1984, The University of Iowa, Iowa City, IA.
3. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatr. 2005, 162(3):441.
4. Andreasen N.C., Pressler M., Nopoulos P., Miller D., Ho B.-C. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol. Psychiatry 2010, 67(3):255-262.
5. Becker D., Drake R. A Working Life for People with Severe Mental Illness 2003, Oxford Press, New York.
6. Bliese P.D., Halverson R.R. Group size and measures of group-level properties: an examination of eta-squared and ICC values. J. Manag. 1998, 24(2):157-172.
7. Bobes J., Arango C., Garcia-Garcia M., Rejas J. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. J. Clin. Psychiatry 2010, 71(3):280.
8. Chang W., Hui C.L., Tang J.Y., Wong G.H., Lam M.M., Chan S.K., Chen E.Y. Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study. Schizophr. Res. 2011, 133(1):22-28.
9. Chang W.C., Yee Man Tang J., Lai Ming Hui C., Hoi Yan Wong G., Kit Wa Chan S., Ho Ming Lee E., Yu Hai Chen E. The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: a prospective three-year follow-up study. Psychiatry Res. 2013, 209(3):353-360.
10. Crespo-Facorro B., Ortiz-García de la Foz V., Mata I., Ayesa-Arriola R., Suarez-Pinilla P., Valdizan E.M., Vázquez-Barquero J.L., Pérez-Iglesias R. Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: A 12-week randomized, flexible-dose, open-label trial. Schizophr. Res. 2013, 33(2):215-220.
11. Evensen J., Røssberg J.I., Barder H., Haahr U., Hegelstad W.t.V., Joa I., Johannessen J.O., Larsen T.K., Melle I., Opjordsmoen S. Flat affect and social functioning: a 10year follow-up study of first episode psychosis patients. Schizophr. Res. 2012, 139(1):99-104.
12. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders 1996, Biometrics Research, New York. Patient edition.
13. Galderisi S., Mucci A., Bitter I., Libiger J., Bucci P., Wolfgang Fleischhacker W., Kahn R.S., E.S. Group Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. Eur. Neuropsychopharmacol. 2013, 23(3):196-204.
14. González-Ortega I., de los Mozos V., Echeburúa E., Mezo M., Besga A., Ruix de Azúa S., González-Pinto A., Gutierrez M., Zorrilla I., González-Pinto A. Working memory as a predictor of negative symptoms and functional outcome in first episode psychosis. Psychiatry Res. 2012, 206(1):8-16.
15. Harvey P.D., Koren D., Reichenberg A., Bowie C.R. Negative symptoms and cognitive deficits: what is the nature of their relationship?. Schizophr. Bull. 2006, 32(2):250-258.
16. Henry L.P., Harris M.G., Amminger G.P., Yuen H.P., Harrigan S.M., Lambert M., Conus P., Schwartz O., Prosser A., Farrelly S. Early Psychosis Prevention and Intervention Centre long term follow up study of first episode psychosis: methodology and baseline characteristics. Early Interv. Psychiatry 2007, 1(1):49-60.
17. Hovington C.L., Bodnar M., Joober R., Malla A.K., Lepage M. Identifying persistent negative symptoms in first episode psychosis. BMC Psychiatry 2012, 12(1):224.
18. Leslie A.M., Friedman O., German T.P. Core mechanisms in 'theory of mind'. Trends Cogn. Sci. 2004, 8(12):528-533.
19. Levine S.Z., Leucht S. Attaining and sustaining remission of predominant negative symptoms. Schizophr. Res. 2013, 143(1):60-64.
20. Lin C.-H., Huang C.-L., Chang Y.-C., Chen P.-W., Lin C.-Y., Tsai G.E., Lane H.-Y. Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia. Schizophr. Res. 2013, 146(1):231-237.
21. Lukoff D., Nuechterlein K.H., Ventura J. Manual for the Expanded Brief Psychiatric Rating Scale (BPRS). Schizophr. Bull. 1986, 12:594-602.
22. Milev P. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am. J. Psychiatr. 2005, 162(3):495-506.
23. Nuechterlein K.H., Dawson M.E., Gitlin M.J., Ventura J., Goldstein M.J., Snyder K.S., Yee C.M., Mintz J. Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress. Schizophr. Bull. 1992, 18(3):387-425.
24. Nuechterlein K.H., Miklowitz D.J., Ventura J., Gitlin M.J., Stoddard M., Lukoff D. Classifying episodes in schizophrenia and bipolar disorder: criteria for relapse and remission applied to recent-onset samples. Psychiatry Res. 2006, 144(2-3):153-166.
25. Nuechterlein K.H., Subotnik K.L., Green M.F., Ventura J., Asarnow R.F., Gitlin M.J., Yee C.M., Gretchen-Doorly D., Mintz J. Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr. Bull. 2011, 37(Suppl. 2):S33-S40.
26. Peña J., Segarra R., Ojeda N., García J., Eguiluz J.I., Gutiérrez M. Do the same factors predict outcome in schizophrenia and non-schizophrenia syndromes after first-episode psychosis? A two-year follow-up study. J. Psychiatr. Res. 2012, 46(6):774-781.
27. Savla G.N., Vella L., Armstrong C.C., Penn D.L., Twamley E.W. Deficits in domains of social cognition in schizophrenia: a meta-analysis of the empirical evidence. Schizophr. Bull. 2013, 39(5):979-992.
28. Siegel S.J., Irani F., Brensinger C.M., Kohler C.G., Bilker W.B., Ragland J.D., Kanes S.J., Gur R.C., Gur R.E. Prognostic variables at intake and long-term level of function in schizophrenia. Am. J. Psychiatr. 2006, 163(3):433-441.
29. Strauss J.S., Carpenter W.T. The prediction of outcome in schizophrenia. I: characteristics of outcome. Arch. Gen. Psychiatry 1972, 27:739-746.
30. Subotnik K.L., Nuechterlein K.H., Ventura J., Green M.F., Hwang S.S. Prediction of the deficit syndrome from initial deficit symptoms in the early course of schizophrenia. Psychiatry Res. 1998, 80:53-59.
31. Subotnik K.L., Nuechterlein K.H., Ventura J., Gitlin M.J., Marder S.R., Mintz J.M., Hellemann G.S., Thornton L.A., Singh I.R. Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia. Am. J. Psychiatr. 2011, 168(3):286-292.
32. Ventura J., Nuechterlein K.H., Lukoff D., Hardesty J.P. A prospective study of stressful life events and schizophrenic relapse. J. Abnorm. Psychol. 1989, 98:407-411.
33. Ventura J., Green M.F., Shaner A., Liberman R.P. Training and quality assurance with the Brief Psychiatric Rating Scale: "the drift busters". Int. J. Methods Psychiatr. Res. 1993, 3(4):221-244.
34. Ventura J., Lukoff D., Nuechterlein K.H., Liberman R.P., Green M.F., Shaner A. Brief Psychiatric Rating Scale (BPRS) expanded version: scales, anchor points, and administration manual. Int. J. Methods Psychiatr. Res. 1993, 3:227-243.
35. Ventura J., Nuechterlein K.H., Subotnik K.L., Gutkind D., Gilbert E.A. Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale. Psychiatry Res. 2000, 97:129-135.
36. Ventura J., Nuechterlein K.H., Green M.F., Horan W.P., Subotnik K.L., Mintz J. The timing of negative symptom exacerbations in relationship to positive symptom exacerbations in the early course of schizophrenia. Schizophr. Res. 2004, 69(2-3):333-342.
37. Ventura J., Hellemann G.S., Thames A.D., Koellner V., Nuechterlein K.H. Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophr. Res. 2009, 113(2):189-199.
38. Ventura J., Hellemann G.S., Thames A.D., Koellner V., Nuechterlein K.H. Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophr. Res. 2009, 113(2):189-199.
39. Ventura J., Subotnik K.L., Guzik L.H., Hellemann G.S., Gitlin M.J., Wood R.C., Nuechterlein K.H. Remission and recovery during the first outpatient year of the early course of schizophrenia. Schizophr. Res. 2011, 132(1):18-23.
40. White C., Stirling J., Hopkins R., Morris J., Montague L., Tantam D., Lewis S. Predictors of 10-year outcome of first-episode psychosis. Psychol. Med. 2009, 39(09):1447-1456.
41. Wing J.K., Cooper J.E., Sartorius N. Measurement and classification of psychiatric symptoms: an introduction manual for the PSE and CATEGO program 1974, Cambridge University Press.